Crook, T., et al. «Effects of Phosphatidylserine in Alzheimer’s Disease», Psychopharmacology Bulletin 28 (1992): 61–66.

Crook, Т. H., et al. «Effects of Phosphatidylserine in Age-Associated Memory Impairment», Neurology 41 (1991): 644–49.

Pepeu, G., I., Marconcini Pepeu, and L. Amaducc, «A Review of Phosphatidylserine Pharmacological and Clinical Effects. Is Phosphatidylserine a Drug for the Ageing Brain?» Pharmacological Research 33 (1996): 73–80.

Villardita, C., et al. «Multicentre Clinical Trial of Brain Phophatidylserine in Elderly Patients with Intellectual Deterioration», Clinical Trials Journal 24 (1987): 84–93.

Zanott, A., L. Valzelli, and G. Toffano, «Chronic Phosphatidylserine Treatment Improves Spatial Memory and Passive Avoidance in Aged Rats», Psychopharmacology 99 (1989): 316–21.

L-теанин

Juneja, L. R., et al. «L-Theanine-A Unique Amino Acid of Green Tea and Its Relaxation Effect in Humans», Trends in Food Science and Technology 10 (1999): 199–204.

Lu, K., et al. «The Acute Effects of L-Theanine in Comparison with Alprazolam on Anticipatory Anxiety in Humans», Human Psychopharmacology 19, no. 7 (October 2004): 457–65.

Sadzuka, Y., et al. «The Effects of Theanine, as a Novel Biochemical Modulator, on the Antitumor Activity of Adriamycin», Cancer Letters 105 (1996): 203–09.

Винпоцетин

Bereczki, D., and I. Fekete, «A Systematic Review of Vinpocetine Therapy in Acute Ischaemic Stroke», European Journal of Clinical Pharmacology 55 (1999): 349–52.

Gulyas, B., et al. «Brain Uptake and Plasma Metabolism of [11C] Vinpocetine: A Preliminary PET Study in a Cynomolgus Monkey», Journal of Neuroimaging 9 (1997): 217–22.

Sitges, М., and V. Nekrassov, «Vinpocetine Prevents 4-Aminopyridine-Induced Changes in the EEG, the Auditory Brainstem Responses and Hearing», Clinical Neurophysiology 115, no. 12 (December 2004): 2711–17.

Thai, L. J., et al. «The Safety and Lack of Efficacy of Vinpocetine in Alzheimer’s Disease», Journal of the American Geriatrics Society 37 (1989): 515–20.

Поливитамины

Fletcher, R. H., and К. M. Fairfield, «Vitamins for Chronic Disease Prevention in Adults: Clinical Applications», Journal of the American Medical Association 287, no. 23 (June 19, 2002): 3127–29.

Витамины группы В

Aarsand, A. К., and S. M. Carlsen, «Folate Administration Reduces Circulating Homocysteine Levels in NIDDM Patients on Long-term Metformin Treatment», Journal of Internal Medicine 244 (1998): 169–74.

Anon., «How Folate Fights Disease», Nature Structural Biology 6 (1999): 293–94.

Baik, H. W., and R. M. Russell, «Vitamin B12 Deficiency in the Elderly», Annual Review of Nutrition 19 (1999): 357–77.

Berry, R. J., et al. «Prevention of Neural-Tube Defects with Folic Acid in China», New England Journal of Medicine 341 (1999): 1485–90.

Bottiglieri, T., «Folate, Vitamin B12, and Neuropsychiatric Disorders», Nutrition Reviews 54 (1996): 382–90.

Boushey, C. J., et al. «A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease. Probable Benefits of Increasing Folic Acid Intakes», Journal of the American Medical Association 274 (1995): 1049–57.

Clarke, R., et al. «Folate, Vitamin B12, and Serum Total Homocysteine Levels in Confirmed Alzheimer’s Disease», Archives of Neurology 55 (1998): 1449–55.

Coppen, A., and J. Bailey, «Enhancement of the Antidepressant Action of Fluoxetine by Folic Acid: A Randomized, Placebo-Controlled Trial», Journal of Affective Disorders 60 (2000): 121–30.

Coppen, A., S. Chaudhry, and C. Swade, «Folic Acid Enhances Lithium Prophylaxis», Journal of Affective Disorders 10 (1986): 9–13.

Czeizel, A. E., and I. Dudas, «Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin Supplementation», New England Journal of Medicine 327 (1992): 1832–35.

Guilarte, Т. R., «Vitamin B6 and Cognitive Development: Recent Research Findings from Human and Animal Studies», Nutrition Reviews 51 (1993): 193–98.

Homocysteine Lowering Trialists’ Collaboration, «Lowering Blood Homocysteine with Folic Acid Based Supplements: Meta-Analysis of Randomized Trials», British Medical Journal 316 (1998): 894–98.

Leklem, J. E., «Vitamin B6», in M.E. Shils et al. eds, «Modern Nutrition in Health and Disease», 9th ed. (Baltimore: Williams and Wilkins, 1999), 413–21.

Lindenbaum, J., et al. «Neuropsvchiatric Disorders Caused by Cobalamin Deficiency in the Absence of Anemia or Macrocytosis», New England Journal of Medicine 318 (1988): 1720–28.

McCaddon, A., and C. L. Kelly, «Familial Alzheimer’s Disease and Vitamin B12 Deficiency», Age and Ageing 23 (1994): 334–37.

Rimm, E. B., et al. «Higher Intake of Folate and Vitamin B6 Is Associated with Low Rates of Coronary Artery Disease in Women», Journal of the American Medical Association 279 (1998): 359–64.

Snowdon, D. A., et al. «Serum Folate and the Severity of Atrophy of the Neocortex in Alzheimer Disease: Findings from the Nun Study», American Journal of Clinical Nutrition 71 (2000): 993–98.

Sumner, A. E., et al. «Elevated Methylmalonic Acid and Total Homocysteine Levels Show High Prevalence of Vitamin B12 Deficiency After Gastric Surgery», Annals of Internal Medicine 124 (1996): 469–76.

Weir, D. G., and J. M. Scott, «Brain Function in the Elderly: Role of Vitamin B12 and Folate», British Medical Bulletin 55 (1999): 669–82.

Wyatt, К. M., et al. «Efficacy of Vitamin B12 in the Treatment of Premenstrual Syndrome: Systemic Review», British Medical Journal (1999): 1375–81.

Витамин C

Age-Related Eye Disease Study Research Group, «A Randomized, Placebo-Controlled, Clinical Trial of High-Dose Supplementation with Vitamins С and E, Beta Carotene, and Zinc for Age-Related Macular Degeneration and Vision Loss: AREDS Report No. 8», Archives of Ophthalmology 119, no. 10 (October 2001): 1417–36.

«Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium, and Carotenoids» (Washington, D.C.: National Academy Press, 2000).

Engelhart, M. J., et al. «Dietary Intake of Antioxidants and Risk of Alzheimer Disease», Journal of the American Medical Association 287, no. 24 (June 26, 2002): 3223–29.

Gray, S. L., et al. «Is Antioxidant Use Protective of Cognitive Function in the Community-Dwelling Elderly?» American Journal of Geriatric Pharmacotherapy I, no. 1 (September 2003): 3–10.